Ex-drug executive Shkreli wins separate fraud trial
April 19, 2017 at 15:42 PM EDT
(Reuters) - Martin Shkreli, the former drug company executive who drew public outcry when he raised the price of a life-saving drug by 5,000 percent, will be tried for securities fraud separately from a lawyer charged alongside him, a Brooklyn federal judge ruled Wednesday.